RFK Jr. May Replace Entire CDC Vaccine Advisory Panel — Then Retracted the Claim
Available in: 中文
Robert Malone, RFK Jr.'s CDC vaccine advisor, claimed the entire ACIP panel would be dissolved — then retracted hours later as a 'miscommunication,' highlighting vaccine policy chaos under HHS.
RFK Jr. May Replace Entire CDC Vaccine Advisory Panel — Then Retracted the Claim
Robert Malone, a controversial figure appointed to the CDC's vaccine advisory committee (ACIP) by RFK Jr., claimed that HHS would dissolve and reform the entire panel — then retracted the claim hours later, calling it a "miscommunication." The episode highlights the chaos surrounding vaccine policy under the new HHS leadership.
The Claim
Malone, known for anti-vaccine views, initially announced:
- Full dissolution: ACIP would be disbanded entirely
- Complete replacement: New members would be selected
- Sources: Malone said he and others were told directly by HHS
The Retraction
Within hours, Malone walked back the claim:
- Miscommunication: "I have now been told that this was a miscommunication"
- Options open: "The decision about how to proceed has not been made, and dissolving and reforming remains one of the options"
- HHS response: "Unless officially announced by us, any assertions about what we are doing next is baseless speculation"
Who Is Robert Malone?
Malone's background is contentious:
- mRNA research: Decades ago, he worked on early mRNA technology, but former colleagues describe him as "unhinged and pretty wacky"
- Anti-vaccine advocacy: Has suggested vaccines cause "a form of AIDS"
- RFK Jr. appointment: Placed on ACIP despite his controversial positions
The Bigger Picture
This incident is part of broader vaccine policy upheaval:
- RFK Jr.'s HHS: The Health and Human Services secretary has repeatedly questioned vaccine safety
- ACIP already weakened: Several members have been replaced since RFK Jr. took office
- Public health concern: Vaccine advisory committees are critical for recommending immunization schedules
Source: Ars Technica | Wall Street Journal
← Previous: NHTSA Rejects Tesla Recall Petition, Deepens FSD Safety InvestigationNext: China Approves First Commercial Brain Chip for Sale, Plans to Dominate Neurotechnology Industry →
0